Viewing nowClopix (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

MFDS item code 201900807 · Approved 2019.02.01 · Insurance code 670501300
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thrombosis in atrial fibrillation
This medication plays a crucial role in vascular health. It is used to improve the symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. Additionally, it alleviates atherosclerotic symptoms by reducing the risk of death, myocardial infarction, and stroke due to cardiovascular concerns in patients with acute coronary syndrome. For patients with atrial fibrillation who have a low bleeding risk and are unsuitable for vitamin K antagonists, this medication helps reduce the risk of stroke and thromboembolism. This medication can effectively improve the symptoms of vascular-related diseases.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg of this medicine once daily, followed by a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. This medicine may be administered with or without food.
This medication prevents blood platelets from sticking together and helps prevent clot formation. This medication is converted into its active form by a specific enzyme (CYP2C19) in the liver; individuals with reduced enzyme function may experience decreased efficacy. Co-administration with drugs that activate the CYP2C19 enzyme may increase drug concentration in blood and elevate bleeding risk, so such combinations should be avoided. Patients with allergies to this drug or its ingredients, bleeding disorders, severe liver damage, or those who are breastfeeding should not take this medication. Patients at high risk of bleeding or with suspected bleeding symptoms should undergo regular blood tests, especially if taken with other antiplatelet or anticoagulant medications, necessitating extra caution. It is recommended to suspend this medication about 5 to 7 days before surgery, and it should be used with caution in patients with lesions prone to bleeding. Taking this medication may prolong bleeding time, leading to prolonged bleeding from minor injuries, so report to a doctor immediately if bleeding does not stop or is severe. Long-term use of this medication may rarely result in thrombocytopenia or severe blood disorders, so consult a healthcare provider immediately if symptoms of infection or unusual symptoms occur. Gastrointestinal symptoms, headaches, dizziness, rashes may occur as side effects, and severe bleeding or allergic reactions require immediate medical attention. The risk to the fetus during pregnancy is not significant, but there is a bleeding risk during delivery, so discontinuation before nerve blocking or delivery is advised. If breastfeeding, consult a doctor regarding the possibility of this medication passing into breast milk and about whether to discontinue breastfeeding. Safety and efficacy in children have not been established, and elderly patients or those with impaired kidney or liver function are at higher bleeding risk and require careful dosage adjustment and observation. Overdose may increase bleeding risk, and since there is no specific antidote, treatment such as platelet transfusion may be necessary for severe bleeding. This medication has many drug interaction potentials, and particularly when taken with drugs that increase bleeding risk, discuss it with a healthcare provider. During the course of taking this medication, inform the medical staff about it when starting new medications or planning surgery.
Hemorrhage, gastrointestinal bleeding, hemorrhage requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, severe neutropenia, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, reduced motor function, tremor, speech disorder, abnormal gait, hyperkinesia, ataxia, sensory disturbance, insomnia, depression, forgetfulness, anxiety, lethargy, cognitive disturbance, abnormal behavior, arthralgia, myalgia, low back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, purpura, melena, hematoma, hemoptysis, muscle hemorrhage, gum bleeding, anemia, pneumonia, sinusitis, visual disturbance, visual field defect, dry eye syndrome, transient blindness, congestion, tinnitus, taste disturbance, urinary incontinence, frequent urination, nonprotein nitrogen increase, uremia, elevated blood urea nitrogen, hypoglycemia, hyperuricemia, elevated liver enzymes, ALT elevation, liver dysfunction, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, generalized edema, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, distension, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, prolonged bleeding time, aplastic anemia, hypochromic anemia, agranulocytosis, granulocytopenia, leukemia, leukopenia, neutropenia, eosinophilia, heavy menstrual bleeding, hemothorax, herpes zoster, erythema multiforme, maculopapular rash, urticaria, renal dysfunction, acute renal failure, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.